Comparison of antibiotic use and antibiotic resistance between a community hospital and tertiary care hospital for evaluation of the antimicrobial stewardship program in Japan

Assessment of risk-adjusted antibiotic use (AU) is recommended to evaluate antimicrobial stewardship programs (ASPs). We aimed to compare the amount and diversity of AU and antimicrobial susceptibility of nosocomial isolates between a 266-bed community hospital (CH) and a 963-bed tertiary care hospital (TCH) in Japan. The days of therapy/100 bed days (DOT) was measured for four classes of broad-spectrum antibiotics predominantly used for hospital-onset infections. The diversity of AU was evaluated using the modified antibiotic heterogeneity index (AHI). With 10% relative DOT for fluoroquinolones and 30% for each of the remaining three classes, the modified AHI equals 1. Multidrug resistance (MDR) was defined as resistance to ≥ 3 anti-Pseudomonas antibiotic classes. The DOT was significantly higher in the TCH than in the CH (10.85 ± 1.32 vs. 3.89 ± 0.93, p < 0.001). For risk-adjusted AU, the DOT was 6.90 ± 1.50 for acute-phase medical wards in the CH, and 8.35 ± 1.05 in the TCH excluding the hematology department. In contrast, the DOT of antibiotics for community-acquired infections was higher in the CH than that in the TCH. As quality assessment of AU, higher modified AHI was observed in the TCH than in the CH (0.832 ± 0.044 vs. 0.721 ± 0.106, p = 0.003), indicating more diverse use in the TCH. The MDR rate in gram-negative rods was 5.1% in the TCH and 3.4% in the CH (p = 0.453). No significant difference was demonstrated in the MDR rate for Pseudomonas aeruginosa and Enterobacteriaceae species between hospitals. Broad-spectrum antibiotics were used differently in the TCH and CH. However, an increased antibiotic burden in the TCH did not cause poor susceptibility, possibly because of diversified AU. Considering the different patient populations, benchmarking AU according to the facility type is promising for inter-hospital comparisons of ASPs.

[1]  H. Ikeuchi,et al.  Correlation between Antimicrobial Resistance and the Hospital-Wide Diverse Use of Broad-Spectrum Antibiotics by the Antimicrobial Stewardship Program in Japan , 2023, Pharmaceutics.

[2]  Dong-Sook Kim,et al.  Development of the Korean Standardized Antimicrobial Administration Ratio as a Tool for Benchmarking Antimicrobial Use in Each Hospital , 2022, Journal of Korean medical science.

[3]  W. Boersma,et al.  Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial. , 2021, The Lancet. Infectious diseases.

[4]  M. Stevens,et al.  COVID-19 and antimicrobial stewardship: lessons learned, best practices, and future implications , 2021, International Journal of Infectious Diseases.

[5]  N. Ohmagari,et al.  Nationwide cross-sectional study of antimicrobial stewardship and antifungal stewardship programs in inpatient settings in Japan , 2021, BMC Infectious Diseases.

[6]  S. Cosgrove,et al.  Significant Regional Differences in Antibiotic Use Across 576 US Hospitals and 11 701 326 Adult Admissions, 2016–2017 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  D. Ashiru-Oredope,et al.  Implementation of antimicrobial stewardship programmes in African countries: a systematic literature review. , 2020, Journal of global antimicrobial resistance.

[8]  G. Bearman,et al.  The effectiveness of formulary restriction and preauthorization at an academic medical center. , 2019, American journal of infection control.

[9]  B. Kyle,et al.  Healthcare coverage in the US and Japan: A comparison. , 2019, Nursing.

[10]  D. Nathwani,et al.  Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review , 2019, Antimicrobial Resistance & Infection Control.

[11]  Amy K. Webb,et al.  The Standardized Antimicrobial Administration Ratio: A New Metric for Measuring and Comparing Antibiotic Use , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  E. Klein,et al.  Is Antimicrobial Resistance a Bigger Problem in Tertiary Care Hospitals Than in Small Community Hospitals in the United States? , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  D. Warren,et al.  Antimicrobial Stewardship in Inpatient Settings in the Asia Pacific Region: A Systematic Review and Meta-analysis. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  C. Hertogh,et al.  Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. , 2016, The Lancet. Infectious diseases.

[15]  Matthew H Samore,et al.  Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Á. Soriano,et al.  Evaluation of a Mixing versus a Cycling Strategy of Antibiotic Use in Critically-Ill Medical Patients: Impact on Acquisition of Resistant Microorganisms and Clinical Outcomes , 2016, PloS one.

[17]  J. Gerber,et al.  Comparison of Prior Authorization and Prospective Audit with Feedback for Antimicrobial Stewardship , 2014, Infection Control &#x0026; Hospital Epidemiology.

[18]  B. Spellberg,et al.  Impact of hospital variables on case mix index as a marker of disease severity. , 2014, Population health management.

[19]  K. Mühlemann,et al.  Impact of Antibiotic Use on Carbapenem Resistance in Pseudomonas aeruginosa: Is There a Role for Antibiotic Diversity? , 2013, Antimicrobial Agents and Chemotherapy.

[20]  N. Shime,et al.  De-escalation of antimicrobial therapy for bacteraemia due to difficult-to-treat Gram-negative bacilli , 2013, Infection.

[21]  J. Rello,et al.  Effect of antibiotic diversity on ventilator-associated pneumonia caused by ESKAPE Organisms. , 2011, Chest.

[22]  I. Gould,et al.  Antibiotic heterogeneity: from concept to practice , 2010, Annals of the New York Academy of Sciences.

[23]  Hiroki Ikeuchi,et al.  Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria. , 2010, The Journal of hospital infection.

[24]  J. Burke,et al.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship , 2007 .

[25]  William E Trick,et al.  Multicenter Intervention Program to Increase Adherence to Hand Hygiene Recommendations and Glove Use and to Reduce the Incidence of Antimicrobial Resistance , 2007, Infection Control &#x0026; Hospital Epidemiology.

[26]  J. Rello,et al.  Impact of diversity of antibiotic use on the development of antimicrobial resistance. , 2006, The Journal of antimicrobial chemotherapy.

[27]  C. Codina,et al.  Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units* , 2006, Critical care medicine.

[28]  H. Ohge,et al.  Effect of Antibiotic Heterogeneity on the Development of Infections with Antibiotic-resistant Gram-negative Organisms in a Non-intensive Care Unit Surgical Ward , 2006, World Journal of Surgery.

[29]  D. Nathwani,et al.  Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. , 2005, The Journal of antimicrobial chemotherapy.

[30]  T. Crabtree,et al.  Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit , 2001, Critical care medicine.